Browsing by Author "Sincar, Sahin"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • No Thumbnail Available
    Publication
    Efficacy of biphosphonates in patients with osteogenesis imperfecta
    (Galenos Yayincilik, 2011-12-01) Eren, Erdal; EREN, ERDAL; Sincar, Sahin; Çakır, Esra Deniz Papatya; Saglam, Halil; SAĞLAM, HALİL; Tarım, Ömer; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Anabilim Dalı.; 0000-0002-1684-1053; 0000-0003-4664-7435; 0000-0002-6598-8262; 0000-0002-5322-5508; GQO-9634-2022; C-7392-2019; JPK-3909-2023; GLN-8241-2022
    Introduction: Osteogenesis imperfecta (OI) is a genetic disorder resulting in increased bone fragility due to defective collagen synthesis. Biphosfonates have been used in children with OI. Herein, we aimed to present clinical and laboratory features of the patients with OI and to evaluate response to biphosphonate therapy.Materials and Methods: The data of 21 patients with OI were evaluated retrospectively and clinical classification was made. Age, gender, auxological data, bone mineral density (BMD), and bone fragility before and after therapy were evaluated. Efficacy of alendronate and pamidronate on the bone density were compared.Results: Of the 21 patients, 12 were male (57.1%), 9 were female (42.9%) and median age was 5.64 years. According the Sillence classification, 10 patients were classified as type I, 9 cases as type III, and 2 cases as type IV. Diagnoses were made by multiple fractures (10 cases), pathological sole fracture (5 cases), blue sclera with history of fracture (2 cases), maternal OI, blue sclera, and decreased BMD (1 case), bone deformity, family history, and blue sclera (1 case). Pamidronate (13 cases) and alendronate (8 cases) were given as medical therapy. Basal DEXA z-score increased from -4.00 at baseline to -2.80 after 12 months of therapy (p< 0.001). When the two therapy models were compared, there was no statistical difference. After one year of therapy, height SDS increased from -2.55 to -1.74 (p= 0.433), and weight SDS increased from -1.79 to -0.51 (p= 0.042). Annual fracture frequency decreased significantly from 2.14 to 0.62 per year (p< 0.001).Conclusions: Three monthly pamidronate or daily alendronate therapy is effective to reduce clinical symptoms and annual fracture rate. Both biphosphonates enhance BMD safely without remarkable side effects. However, duration of therapy and possible side effects in the long run are still unclear and further research in larger groups is necessary.
  • Thumbnail Image
    Publication
    Evaluation of patients with tuberculous meningitis
    (Aves Yayıncılık, 2011-09-01) Bozdemir, Şefika Elmas; Çelebi, Solmaz; Hacımustafaoğlu, Mustafa; Çakır, Deniz; Aygün, F. Deniz; Çelik, Uğur; Sincar, Sahin; Özdener, Melek; Bozdemir, Şefika Elmas; ÇELEBİ, SOLMAZ; HACIMUSTAFAOĞLU, MUSTAFA KEMAL; Çakır, Deniz; Aygün, F. Deniz; KILIÇ, UĞUR; Sincar, Sahin; Özdener, Melek; Uludağ Üniversitesi/Tıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Anabilim Dalı/Çocuk Enfeksiyon Hastalıkları Bilim Dalı.; Uludağ Üniversitesi/Tıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Anabilim Dalı.; 0000-0003-4646-660X; 0000-0002-7056-0615; AAC-9239-2021; GQP-2135-2022; HZV-5920-2023; JHN-1091-2023; CTG-5805-2022; JHS-0258-2023; FYK-3292-2022; FTD-2318-2022
    Objective: Tuberculous meningitis is a form of extrapulmonary tuberculosis which has the highest mortality and morbidity rate. The aim of this study is to evaluate clinical signs and treatment regimens of patients with tuberculous meningitis.Material and Methods: Epidemiological properties, clinical signs, treatment regimens and prognosis of 11 patients with tuberculous meningitis in the Uludag University Medical Faculty Pediatric Infectious Disease Department between 2005- 2010 were evaluated.Results: Of the patients, 81.8% were boys with a mean age of 5.15 +/- 1.69 years (2 months- 15 years). The patients < 1year made up 36.3%. The most frequent complaints were fever and drowsiness in 45.5%, headache, nausea, vomiting in 18.2%, drowsiness in 18.2%. Physical examinations revealed fever and drowsiness in 63.6% and neck stiffness in 36.4%. Four patients (36.4%) had a person with active tuberculosis in his/her family. Tuberculin skin test (TST) was applied to all patients and resulted in > 15 mm enduration in 45.5%. BCG scarring was present in 72.7% of patients. Acid- alcohol- resistant bacillus (AARB) was seen in the cerebrospinal fluid (CSF) of 18.2% patients and grew Mycobacterium tuberculosis complex in cultures. Average cell count in CSF was 130 +/- 54.4, 75% lymphocyte in giemza staining. Average CSF protein 173.3 +/- 23.5 mg/dL, CSF chlorine 109.3 +/- 4.1mEq/L, CSF LDH 390.2 +/- 331.1 IU/L were found. Of the patients, 9.1% were in stage 1, 45.5% in stage 2 and 45.5% in stage 3 on admission. Cranial MRI revealed hydrocephaly + leptomeningeal staining in 45.5%, tuberculoma+ leptomeningeal staining in 18.2%, leptomeningeal staining in 27.3% and hydrocephaly in 9.1%. Of the patients, 81.8% were treated with izoniazid, rifampicin, pyrazinamid and streptomycine or ethambutole for two months initially, with izoniazid, rifampicin during the following 10 months. Prednisolone at 2 mg/kg/day was given to patients. Ventriculoperitoneal shunt was placed in 36.4% of patients for hydrocephalus. Neurological sequelae developed in 72.7% of patients. Of all the patients, 36.4% had mental- motor retardation, 27.3% learning difficulties and 9.1% hearing loss. One patient (9.1%) died.Conclusion: Because tuberculous meningitis is an infectious disease with high mortality and morbidity rates in childhood, rapid diagnosis and treatment is necessary for reducing complications.